DS
COCP icon

DRW Securities’s Cocrystal Pharma COCP Stock Holding History

DRW Securities’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,593
Closed -$32.9K – 1368
2025
Q4 		$32.9K Buy
+33,593
New +$35.6K ﹤0.01% 1145

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

DRW Securities's COCP Position: Q1 2026 in Review

DRW Securities sold out of Cocrystal Pharma (COCP) in Q1 2026, closing a stake of 33,593 shares — an estimated $32.9K sold.

DRW Securities first reported a position in COCP in Q4 2025 and held it in 1 quarter. The position peaked at $32.9K in Q4 2025. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

  • DRW Securities reported no remaining Cocrystal Pharma position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 33,593 Cocrystal Pharma shares in Q1 2026, an estimated $32.9K.
  • DRW Securities first reported a position in Cocrystal Pharma in Q4 2025 and held it in 1 quarter.
  • DRW Securities's Cocrystal Pharma position peaked at $32.9K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.